Registry of Toxic Effects of Chemical Substances (RTECS)
ShareCompartir
Sulfur dioxide
RTECS #
WS4550000CAS #
7446-09-5; 8014-94-6; 12396-99-5; 83008-56-4; 89125-89-3Updated
September 201Molecular Weight
64.06Molecular Formula
O2SSynonyms
Fermenicide liquidFermenicide powder
Schwefeldioxyd (German)
Siarki dwutlenek (Polish)
Sulfur dioxide (ACGIH:OSHA)
Sulfur oxide
Sulfur superoxide
Sulfurous acid anhydride
Sulfurous anhydride
Sulfurous oxide
Sulphur dioxide
Skin and Eye Irritation and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| eye /rabbit | 6 ppm/32D | mild | JPCAAC 10,17,1960 |
Mutation Data and Reference
| System Test | Route/Organism/Tissue | Dose | Reference |
|---|---|---|---|
| Cytogenetic Analysis | multiple/human | 42 mg/m3 | MUREAV 359,25,1996 |
| Cytogenetic Analysis | other cell types/domestic animal | 5 mmol/L | MUREAV 39,149,1977 |
| Cytogenetic Analysis | other cell types/cattle | 2500 µmol/L | MUREAV 39,149,1977 |
| Cytogenetic Analysis | inhalation/mouse | 14 µg/L/4H/7D | MUTAEX 17,215,2002 |
| DNA adduct | inhalation/rat | 72 mg/kg/300D- intermittent | CALEDQ 139,189,1999 |
| DNA Damage | inhalation/mouse | 7 µg/L | TXAPA9 197,239,2004 |
| DNA Damage | inhalation/mouse | 14 µg/L/7D- intermittent | EMMUEG 46,150,2005 |
| DNA Damage | lymphocyte/human | 5700 ppb | MUREAV 39,149,1977 |
| DNA inhibition | lymphocyte/human | 5700 ppb | MUREAV 39,149,1977 |
| micronucleus test | inhalation/mouse | 28 µg/L/5D- intermittent | INHTE5 15,1053,2003 |
| mutation in microorganisms | /Other microorganisms | 10 mmol/L (-enzymatic activation step) | MUREAV 39,149,1977 |
| mutation in microorganisms | /Saccharomyes cerevisiae | 5 µmol/L (-enzymatic activation step) | MUREAV 39,149,1977 |
| other mutation test systems | /Escherichia coli | 2 mmol/L | CBINA8 43,289,1983 |
| other mutation test systems | lymphocyte/human | 5700 ppb | MUREAV 39,149,1977 |
| other mutation test systems | other cell types/cattle | 2500 µmol/L | MUREAV 39,149,1977 |
| sex chromosome loss and nondisjunction | oral/Drosophila melanogaster | 200 µmol/L | MUREAV 39,149,1977 |
| sister chromatid exchange | multiple/human | 42 mg/m3 | MUREAV 359,25,1996 |
Reproductive Effects Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| inhalation/rat | 4 mg/m3/24H (72D prior to copulation) | Reproductive: Maternal effects: Menstrual cycle changes or disorders Reproductive: Maternal effects: Parturition Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | HYSAAV 35(4-6),277,1970 |
| inhalation/rat | 4 mg/m3/24H (72D prior to copulation) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Delayed effects | HYSAAV 35(4-6),277,1970 |
| inhalation/rat | 4970 µg/m3/12H (12W prior to copulation) | Reproductive: Maternal effects: Menstrual cycle changes or disorders Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | HYSAAV 36(7-9),178,1971 |
| inhalation/rat | 30 ppm/6H (21W male) | Reproductive: Paternal effects: Testes, epididymis, sperm duct | JTEHD6 21,141,1987 |
| inhalation/mouse | 25 ppm/7H (6-15D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | FCTXAV 18,743,1980 |
| inhalation/mouse | 25 ppm/7H (6-15D pregnant) | Reproductive: Specific developmental abnormalities: Musculoskeletal system | NTIS** CONF-771017 |
| inhalation/mouse | 32 ppm/24H (7-18D pregnant) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Behavioral | TJADAB 31,9B,1985 |
| inhalation/mouse | 5 ppm (9D prior to copulation/1-14D pregnant) | Reproductive: Effects on newborn: Behavioral | NETEEC 20,543,1998 |
| inhalation/rabbit | 70 ppm/7H (6-18D pregnant) | Reproductive: Specific developmental abnormalities: Musculoskeletal system | NTIS** CONF-771017 |
Tumorigenic Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| inhalation/mouse | lowest published toxic concentration: 500 ppm/5M/30W- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Lung, Thorax, or Respiration: Tumors | BJCAAI 21,606,1967 |
| inhalation/rat | lowest published toxic concentration: 72 mg/kg/300D- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Tumorigenic: Facilitates action of known carcinogens Lung, Thorax, or Respiration: Tumors | CALEDQ 139,189,1999 |
Acute Toxicity Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| inhalation/frog | Lowest published lethal concentration: 1 pph/15M | HBAMAK 4,1396,1935 | |
| inhalation/guinea pig | lowest published toxic concentration: 100 ppm/30M | Cardiac: Pulse rate decreased with fall in BP | TOXID9 66,193,2002 |
| inhalation/guinea pig | lowest published toxic concentration: 100 ppm/1H | TOXID9 60,425,2001 | |
| inhalation/guinea pig | lowest published toxic concentration: 50 ppm/1H | Olfaction: Other olfaction effects Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Lung, Thorax, or Respiration: Other changes | TOXID9 60,425,2001 |
| inhalation/guinea pig | Lowest published lethal concentration: 1039 ppm/24H | CBTIAE 10,281,1939 | |
| inhalation/human | lowest published toxic concentration: 2.2 mg/m3/30M | Lung, Thorax, or Respiration: Other changes | VCVN5* -,226,1993 |
| inhalation/human | lowest published toxic concentration: 2.9 mg/m3/60M | Olfaction: Other olfaction effects | VCVN5* -,226,1993 |
| inhalation/human | lowest published toxic concentration: 2.9 mg/m3/10M | Cardiac: Pulse rate increased without fall in BP Lung, Thorax, or Respiration: Dyspnea | VCVN5* -,226,1993 |
| inhalation/human | Lowest published lethal concentration: 1000 ppm/10M | Lung, Thorax, or Respiration: Respiratory depression | CTOXAO 5,198,1972 |
| inhalation/human | lowest published toxic concentration: 3 ppm/5D | Lung, Thorax, or Respiration: Other changes | TXAPA9 22,319,1972 |
| inhalation/human | lowest published toxic concentration: 12 ppm/1H | Lung, Thorax, or Respiration: Other changes | SAIGBL 14,449,1972 |
| inhalation/human | Lowest published lethal concentration: 3000 ppm/5M | TABIA2 3,231,1933 | |
| inhalation/mammal (species unspecified) | lowest published toxic concentration: 19.6 mg/m3 | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Other changes Endocrine: Other changes | VCVN5* -,224,1993 |
| inhalation/mammal (species unspecified) | lowest published toxic concentration: 80 mg/m3 | Olfaction: Change in sensation of smell Lung, Thorax, or Respiration: Dyspnea | VCVN5* -,224,1993 |
| inhalation/mammal (species unspecified) | lowest published toxic concentration: 740 mg/m3 | Olfaction: Other olfaction effects Gastrointestinal: Decreased motility or constipation | VCVN5* -,224,1993 |
| inhalation/mammal (species unspecified) | Lowest published lethal concentration: 3000 ppm/5M | AEPPAE 138,65,1928 | |
| inhalation/mouse | lethal concentration (50 percent kill): 3000 ppm/30M | Behavioral: Convulsions or effect on seizure threshold Behavioral: Change in motor activity (specific assay) | JCTODH 4,236,1977 |
| inhalation/mouse | lethal concentration (50 percent kill): 3000 ppm/30M | ENTOX* ,115,2005 | |
| inhalation/rat | lowest published toxic concentration: 20 mg/m3/5H | Behavioral: Change in motor activity (specific assay) Behavioral: Aggression | VCVN5* -,225,1993 |
| inhalation/rat | lowest published toxic concentration: 30 mg/m3 | Peripheral Nerve and Sensation: Recording from peripheral motor nerve Blood: Normocytic anemia Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | VCVN5* -,225,1993 |
| inhalation/rat | lethal concentration (50 percent kill): 2168 mg/m3 | Behavioral: Change in motor activity (specific assay) Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea | VCVN5* -,224,1993 |
| inhalation/rat | lowest published toxic dose: 57.3 mg/m3/6H | Vascular: BP lowering not characterized in autonomic section | INHTE5 15,951,2003 |
| inhalation/rat | lowest published toxic concentration: 80 mg/m3/4H | Lung, Thorax, or Respiration: Other changes | TPKVAL 14,73,1975 |
| inhalation/rat | lowest published toxic concentration: 57.3 mg/m3/6H | Vascular: BP lowering not characterized in autonomic section | INHTE5 15,951,2003 |
| inhalation/rat | lethal concentration (50 percent kill): 2520 ppm/1H | ENTOX* ,115,2005 |
Other Multiple Dose Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| inhalation/cattle | lowest published toxic concentration: 1 ppm/10D- intermittent | Lung, Thorax, or Respiration: Other changes Blood: Other changes Immunological Including Allergic: Decrease in cellular immune response | TOXID9 72,230,2003 |
| inhalation/cattle | lowest published toxic concentration: 5 ppm/7D- intermittent | Lung, Thorax, or Respiration: Other changes Blood: Other changes Immunological Including Allergic: Decrease in cellular immune response | TOXID9 72,230,2003 |
| inhalation/Dog | lowest published toxic concentration: 1 ppm/90M/1Y- intermittent | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi | AEHLAU 30,249,1975 |
| inhalation/Dog | lowest published toxic concentration: 500 ppm/2H/21W- intermittent | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Lung, Thorax, or Respiration: Respiratory depression | JTEHD6 13,945,1984 |
| inhalation/guinea pig | lowest published toxic concentration: 10 ppm/1H/30D- intermittent | Liver: Other changes Kidney, Ureter, and Bladder: Other changes Biochemical: Metabolism (intermediary): Lipids including transport | INHEAO 23,81,1985 |
| inhalation/human | lowest published toxic concentration: 4.5 mg/m3/24H/5D- continuous | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | VCVN5* -,227,1989 |
| inhalation/mouse | lowest published toxic concentration: 22 mg/m3/6H/7D- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases | ETOPFR 13,1,2003 |
| inhalation/mouse | lowest published toxic concentration: 56 mg/m3/6H/7D- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases | ETOPFR 13,1,2003 |
| inhalation/mouse | lowest published toxic concentration: 14 mg/m3/7D- intermittent | Lung, Thorax, or Respiration: Other changes Immunological Including Allergic: Increase in cellular immune response | INHTE5 17,303,2005 |
| inhalation/mouse | lowest published toxic concentration: 28 mg/m3/5D- intermittent | Lung, Thorax, or Respiration: Changes in lung weight Liver: Changes in liver weight Kidney, Ureter, and Bladder: Changes in kidney weight | INHTE5 15,1053,2003 |
| inhalation/mouse | lowest published toxic concentration: 64 mg/m3/7D- intermittent | Brain and Coverings: Other degenerative changes Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | AECTCV 45,423,2003 |
| inhalation/mouse | lowest published toxic concentration: 22 mg/m3/7D- intermittent | Gastrointestinal: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes | INHTE5 15,397,2003 |
| inhalation/mouse | lowest published toxic concentration: 56 mg/m3/7D- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases | INHTE5 15,397,2003 |
| inhalation/mouse | lowest published toxic concentration: 56 mg/m3/7D- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases | INHTE5 15,397,2003 |
| inhalation/mouse | lowest published toxic concentration: 112 mg/m3/7D- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases | INHTE5 15,397,2003 |
| inhalation/mouse | lowest published toxic concentration: 10 ppm/7W- intermittent | Behavioral: Food intake (animal) Behavioral: Alteration of operant conditioning Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | NETEEC 29,211,2007 |
| inhalation/mouse | lowest published toxic dose: 10 ppm/7D- intermittent | Blood: Other changes | MUREAV 697,38,2010 |
| inhalation/rabbit | lowest published toxic concentration: 200 mg/m3/3H/13W- intermittent | Cardiac: Other changes Liver: Other changes Blood: Hemorrhage | GISAAA 24(6),22,1959 |
| inhalation/rat | lowest published toxic concentration: 28.6 mg/m3/3D- intermittent | Vascular: BP lowering not characterized in autonomic section | INHTE5 15,951,2003 |
| inhalation/rat | lowest published toxic concentration: 28 mg/m3/7D- intermittent | Liver: Other changes Biochemical: Metabolism (intermediary): Other proteins | TXCYAC 216,253,2005 |
| inhalation/rat | lowest published toxic concentration: 28 mg/m3/7D- intermittent | Lung, Thorax, or Respiration: Other changes Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | TOLED5 160,34,2005 |
| inhalation/rat | lowest published toxic concentration: 28 mg/m3/7D- intermittent | Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) | TOLED5 160,34,2005 |
| inhalation/rat | lowest published toxic concentration: 300 ppm/4H/44D- intermittent | Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases | EJPHAZ 487,7,2004 |
| inhalation/rat | lowest published toxic concentration: 300 ppm/2H/10D- intermittent | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Lung, Thorax, or Respiration: Respiratory depression | TXAPA9 197,175,2004 |
| inhalation/rat | lowest published toxic concentration: 10 ppm/1H/6W- intermittent | Brain and Coverings: Other degenerative changes Eye: Other eye effects Behavioral: Food intake (animal) | NETEEC 25,587,2003 |
| inhalation/rat | lowest published toxic concentration: 10 ppm/1H/6W- intermittent | Behavioral: Fluid intake Biochemical: Metabolism (intermediary): Lipids including transport | NETEEC 25,587,2003 |
| inhalation/rat | lowest published toxic concentration: 8.5 mg/m3/24H/65D- continuous | Peripheral Nerve and Sensation: Recording from peripheral motor nerve Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Lung, Thorax, or Respiration: Emphysema | VCVN5* -,228,1989 |
| inhalation/rat | lowest published toxic concentration: 143 mg/m3/6H/17W- intermittent | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Liver: Hepatitis (hepatocellular necrosis), diffuse Endocrine: Hyperglycemia | VCVN5* -,229,1989 |
| inhalation/rat | lowest published toxic concentration: 51.2 mg/m3/6H/17W- intermittent | Olfaction: Other olfaction effects Gastrointestinal: Other changes Liver: Liver function tests impaired | VCVN5* -,229,1989 |
| inhalation/rat | lowest published toxic concentration: 100 ppm/5H/28D- intermittent | Lung, Thorax, or Respiration: Other changes Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes | CBPCEE 114,89,1996 |
| inhalation/rat | lowest published toxic concentration: 4910 µg/m3/6H/17W- intermittent | Blood: Pigmented or nucleated red blood cells Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases | GISAAA 41(5),6,1976 |
| inhalation/rat | lowest published toxic concentration: 500 µg/m3/96D- intermittent | Brain and Coverings: Changes in surface EEG Behavioral: Change in motor activity (specific assay) Biochemical: Metabolism (intermediary): Xanthine, purine or nucleotides including urate | GISAAA 34(2),3,1969 |
| inhalation/rat | lowest published toxic concentration: 400 ppm/3H/6W- intermittent | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi | ATSUDG 9,431,1986 |
| inhalation/rat | lowest published toxic concentration: 10 ppm/24H/14D- intermittent | Behavioral: Food intake (animal) Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport | ARTODN 70,164,1996 |
| parenteral/rat | lowest published toxic dose: 250 ppm/4D- intermittent | Lung, Thorax, or Respiration: Other changes Biochemical: Metabolism (intermediary): Other | TOXID9 44,190,2005 |
Reviews
| Organization | Standard | Reference |
|---|---|---|
| American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-short term exposure limit 0.25 ppm | DTLVS* TLV/BEI,2013 |
| American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Not classifiable as a human carcinogen | DTLVS* TLV/BEI,2013 |
| International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMEMDT 54,131,1992 |
| International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 54,131,1992 |
| International Agency for Research on Cancer (IARC) | Cancer Review:Group 3 | IMEMDT 54,131,1992 |
| TOXICOLOGY REVIEW | MUREAV 558,7,2004 | |
| TOXICOLOGY REVIEW | NTIS** PB228-002 | |
| TOXICOLOGY REVIEW | EVHPAZ 10,35,1975 | |
| TOXICOLOGY REVIEW | GEIGAI 20,299,1973 | |
| TOXICOLOGY REVIEW | AEHLAU 16,903,1968 | |
| TOXICOLOGY REVIEW | ENVRAL 16,139,1978 | |
| TOXICOLOGY REVIEW | NTIS** CONF-691001 | |
| TOXICOLOGY REVIEW | AMIHBC 10,455,1954 | |
| TOXICOLOGY REVIEW | TPHSDY 23,311,2002 | |
| TOXICOLOGY REVIEW | TOLED5 140-141,195,2003 | |
| TOXICOLOGY REVIEW | TOLED5 140-141,213,2003 | |
| TOXICOLOGY REVIEW | TPHSDY 24,609,2003 | |
| TOXICOLOGY REVIEW | NETOX* 26,555,2005 | |
| TOXICOLOGY REVIEW | DIMON* 46,551,2000 | |
| TOXICOLOGY REVIEW | ENTOX* -,115,2005 | |
| TOXICOLOGY REVIEW | MUREAV 658,124,2008 | |
| TOXICOLOGY REVIEW | HUTOX* -,259,1996 | |
| TOXICOLOGY REVIEW | HUTOX* -,661,1996 | |
| TOXICOLOGY REVIEW | MUREAV 674,45,2009 | |
| TOXICOLOGY REVIEW | MUREAV 674,62,2009 | |
| TOXICOLOGY REVIEW | MUREAV 674,73,2009 | |
| TOXICOLOGY REVIEW | MUREAV 636,144,2007 | |
| TOXICOLOGY REVIEW | MUREAV 636,36,2007 | |
| TOXICOLOGY REVIEW | PRESR* 7,123,2006 | |
| TOXICOLOGY REVIEW | MUREAV 717,38,2011 | |
| TOXICOLOGY REVIEW | MUREAV 717,46,2011 |
Standards and Regulations
| Organization | Standard | Reference |
|---|---|---|
| Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION | FEREAC 54,7740,1989 | |
| Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF PESTICIDES | Supported | RBREV* -,320,1998 |
| Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 5 ppm (13 mg/m3) | DTLVS* 3,238,1971 |
| Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
| Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
| Occupational Exposure Limit-ARAB Republic of Egypt | time-weighted average 5 ppm (13 mg/m3), JAN1993 | |
| Occupational Exposure Limit-AUSTRALIA | time-weighted average 2 ppm (5.2 mg/m3), short term exposure limit 5 ppm (13 mg/m3), JUL2008 | |
| Occupational Exposure Limit-AUSTRIA | MAK-TMW 2 ppm (5 mg/m3);KZW 4 ppm (10 mg/m3), 2007 | |
| Occupational Exposure Limit-BELGIUM | time-weighted average 2 ppm (5.3 mg/m3), short term exposure limit 5 ppm (13 mg/m3), MAR2002 | |
| Occupational Exposure Limit-DENMARK | time-weighted average 0.5 ppm (1.3 mg/m3), MAY2011 | |
| Occupational Exposure Limit-FINLAND | time-weighted average 1 ppm (2.7 mg/m3), short term exposure limit 4 ppm (11 mg/m3), NOV2011 | |
| Occupational Exposure Limit-FRANCE | VME 2 ppm (5 mg/m3), VLE 5 ppm (10 mg/m3), FEB2006 | |
| Occupational Exposure Limit-GERMANY | MAK 0.5 ppm (1.3 mg/m3), 2011 | |
| Occupational Exposure Limit-HUNGARY | time-weighted average 5 mg/m3, short term exposure limit 5 mg/m3, SEP2000 | |
| Occupational Exposure Limit-ICELAND | time-weighted average 0.5 ppm (1.3 mg/m3), NOV2011 | |
| Occupational Exposure Limit-KOREA | time-weighted average 2 ppm (5 mg/m3), short term exposure limit 5 ppm (10 mg/m3), 2006 | |
| Occupational Exposure Limit-MEXICO | time-weighted average 2 ppm (5 mg/m3);short term exposure limit 5 ppm (10 mg/m3), 2004 | |
| Occupational Exposure Limit-NEW ZEALAND | time-weighted average 2 ppm (5.2 mg/m3), short term exposure limit 5 ppm (13 mg/m3), JAN2002 | |
| Occupational Exposure Limit-NORWAY | time-weighted average 2 ppm (5 mg/m3), JAN1999 | |
| Occupational Exposure Limit-PERU | time-weighted average 2 ppm (5,2 mg/m3); short term exposure limit 5 ppm (13 mg/m3), JUL2005 | |
| Occupational Exposure Limit-POLAND | MAC(time-weighted average) 2 mg/m3, MAC(short term exposure limit) 5 mg/m3, JAN1999 | |
| Occupational Exposure Limit-RUSSIA | short term exposure limit 10 mg/m3, Skin, JUN2003 | |
| Occupational Exposure Limit-SWEDEN | time-weighted average 2 ppm (5 mg/m3), ceiling concentration 5 ppm (13 mg/m3), JUN2005 | |
| Occupational Exposure Limit-SWITZERLAND | ceiling concentration 0.5 ppm (1.3 mg/m3), JAN2011 | |
| Occupational Exposure Limit-THAILAND | time-weighted average 5 ppm (13 mg/m3), JAN1993 | |
| Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 5 mg/m3, 2003 | |
| Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 5 ppm (13 mg/m3), JAN1993 | |
| Occupational Exposure Limit-TURKEY | time-weighted average 5 ppm (13 mg/m3), JAN1993 | |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 5 ppm (13 mg/m3) | CFRGBR 29,1926.55,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 5 ppm (13 mg/m3) | CFRGBR 41,50-204.50,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 5 ppm (13 mg/m3) | CFRGBR 29,1910.1000,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 5 ppm (13 mg/m3) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
| Organization | Standard | Reference |
|---|---|---|
| National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO SULFUR DIOXIDE-air | 10H time-weighted average 2 ppm;short term exposure limit 5 ppm | NIOSH* DHHS #92-100,1992 |
| National Occupational Exposure Survey 1983 | Hazard Code 70860; Number of Industries 59; Total Number of Facilities 2465; Number of Occupations 58; Total Number of Employees Exposed 55033; Total Number of Female Employees Exposed 8990 | |
| National Occupational Hazard Survey 1974 | Hazard Code 70860; Number of Industries 85; Total Number of Facilities 6399; Number of Occupations 61; Total Number of Employees Exposed 51398 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division